Abstract
We report the spectrum of 59 ATM mutations observed in ataxia-telangiectasia (A-T) patients in the British Isles. Of 51 ATM mutations identified in families native to the British Isles, 11 were founder mutations, and 2 of these 11 conferred a milder clinical phenotype with respect to both cerebellar degeneration and cellular features. We report, in two A-T families, an ATM mutation (7271T-->G) that may be associated with an increased risk of breast cancer in both homozygotes and heterozygotes (relative risk 12.7; P=. 0025), although there is a less severe A-T phenotype in terms of the degree of cerebellar degeneration. This mutation (7271T-->G) also allows expression of full-length ATM protein at a level comparable with that in unaffected individuals. In addition, we have studied 18 A-T patients, in 15 families, who developed leukemia, lymphoma, preleukemic T-cell proliferation, or Hodgkin lymphoma, mostly in childhood. A wide variety of ATM mutation types, including missense mutations and in-frame deletions, were seen in these patients. We also show that 25% of all A-T patients carried in-frame deletions or missense mutations, many of which were also associated with expression of mutant ATM protein.
Full Text
The Full Text of this article is available as a PDF (738.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Athma P., Rappaport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet. 1996 Dec;92(2):130–134. doi: 10.1016/s0165-4608(96)00328-7. [DOI] [PubMed] [Google Scholar]
- Byrd P. J., McConville C. M., Cooper P., Parkhill J., Stankovic T., McGuire G. M., Thick J. A., Taylor A. M. Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. Hum Mol Genet. 1996 Jan;5(1):145–149. doi: 10.1093/hmg/5.1.145. [DOI] [PubMed] [Google Scholar]
- Easton D. F. Cancer risks in A-T heterozygotes. Int J Radiat Biol. 1994 Dec;66(6 Suppl):S177–S182. doi: 10.1080/09553009414552011. [DOI] [PubMed] [Google Scholar]
- FitzGerald M. G., Bean J. M., Hegde S. R., Unsal H., MacDonald D. J., Harkin D. P., Finkelstein D. M., Isselbacher K. J., Haber D. A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 1997 Mar;15(3):307–310. doi: 10.1038/ng0397-307. [DOI] [PubMed] [Google Scholar]
- Gardella R., Belletti L., Zoppi N., Marini D., Barlati S., Colombi M. Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. Am J Hum Genet. 1996 Aug;59(2):292–300. [PMC free article] [PubMed] [Google Scholar]
- Gilad S., Khosravi R., Shkedy D., Uziel T., Ziv Y., Savitsky K., Rotman G., Smith S., Chessa L., Jorgensen T. J. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet. 1996 Apr;5(4):433–439. doi: 10.1093/hmg/5.4.433. [DOI] [PubMed] [Google Scholar]
- Keegan K. S., Holtzman D. A., Plug A. W., Christenson E. R., Brainerd E. E., Flaggs G., Bentley N. J., Taylor E. M., Meyn M. S., Moss S. B. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev. 1996 Oct 1;10(19):2423–2437. doi: 10.1101/gad.10.19.2423. [DOI] [PubMed] [Google Scholar]
- Krawczak M., Cooper D. N. The human gene mutation database. Trends Genet. 1997 Mar;13(3):121–122. doi: 10.1016/s0168-9525(97)01068-8. [DOI] [PubMed] [Google Scholar]
- Lakin N. D., Weber P., Stankovic T., Rottinghaus S. T., Taylor A. M., Jackson S. P. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene. 1996 Dec 19;13(12):2707–2716. [PubMed] [Google Scholar]
- Liu Q., Sommer S. S. Restriction endonuclease fingerprinting (REF): a sensitive method for screening mutations in long, contiguous segments of DNA. Biotechniques. 1995 Mar;18(3):470–477. [PubMed] [Google Scholar]
- McConville C. M., Stankovic T., Byrd P. J., McGuire G. M., Yao Q. Y., Lennox G. G., Taylor M. R. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996 Aug;59(2):320–330. [PMC free article] [PubMed] [Google Scholar]
- Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995 Jun 23;268(5218):1749–1753. doi: 10.1126/science.7792600. [DOI] [PubMed] [Google Scholar]
- Savitsky K., Sfez S., Tagle D. A., Ziv Y., Sartiel A., Collins F. S., Shiloh Y., Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet. 1995 Nov;4(11):2025–2032. doi: 10.1093/hmg/4.11.2025. [DOI] [PubMed] [Google Scholar]
- Swift M., Morrell D., Cromartie E., Chamberlin A. R., Skolnick M. H., Bishop D. T. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet. 1986 Nov;39(5):573–583. [PMC free article] [PubMed] [Google Scholar]
- Swift M., Morrell D., Massey R. B., Chase C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991 Dec 26;325(26):1831–1836. doi: 10.1056/NEJM199112263252602. [DOI] [PubMed] [Google Scholar]
- Taylor A. M., Flude E., Laher B., Stacey M., McKay E., Watt J., Green S. H., Harding A. E. Variant forms of ataxia telangiectasia. J Med Genet. 1987 Nov;24(11):669–677. doi: 10.1136/jmg.24.11.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor A. M., Metcalfe J. A., Thick J., Mak Y. F. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996 Jan 15;87(2):423–438. [PubMed] [Google Scholar]
- Telatar M., Wang Z., Udar N., Liang T., Bernatowska-Matuszkiewicz E., Lavin M., Shiloh Y., Concannon P., Good R. A., Gatti R. A. Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet. 1996 Jul;59(1):40–44. [PMC free article] [PubMed] [Google Scholar]
- Uziel T., Savitsky K., Platzer M., Ziv Y., Helbitz T., Nehls M., Boehm T., Rosenthal A., Shiloh Y., Rotman G. Genomic Organization of the ATM gene. Genomics. 1996 Apr 15;33(2):317–320. doi: 10.1006/geno.1996.0201. [DOI] [PubMed] [Google Scholar]
- Vorechovský I., Luo L., Dyer M. J., Catovsky D., Amlot P. L., Yaxley J. C., Foroni L., Hammarström L., Webster A. D., Yuille M. A. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet. 1997 Sep;17(1):96–99. doi: 10.1038/ng0997-96. [DOI] [PubMed] [Google Scholar]
- Wright J., Teraoka S., Onengut S., Tolun A., Gatti R. A., Ochs H. D., Concannon P. A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. Am J Hum Genet. 1996 Oct;59(4):839–846. [PMC free article] [PubMed] [Google Scholar]
- Xu Y., Ashley T., Brainerd E. E., Bronson R. T., Meyn M. S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 1996 Oct 1;10(19):2411–2422. doi: 10.1101/gad.10.19.2411. [DOI] [PubMed] [Google Scholar]
- Ying K. L., Decoteau W. E. Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia. Cancer Genet Cytogenet. 1981 Dec;4(4):311–317. doi: 10.1016/0165-4608(81)90027-3. [DOI] [PubMed] [Google Scholar]